What is Harbin Pharmaceutical Group Co Inventory-to-Revenue?
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Harbin Pharmaceutical Group Co's Average Total Inventories for the quarter that ended in Mar. 2024 was ¥1,912 Mil. Harbin Pharmaceutical Group Co's Revenue for the
three
months ended in Mar. 2024 was ¥4,142 Mil.
Harbin Pharmaceutical Group Co's Inventory-to-Revenue for the quarter that ended in Mar. 2024 was 0.46.
Harbin Pharmaceutical Group Co's Inventory-to-Revenue for the quarter that ended in Mar. 2024
declined
from Dec. 2023 (0.47) to Dec. 2023 (0.46)
A decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:
1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Harbin Pharmaceutical Group Co's Days Inventory for the
three
months ended in Mar. 2024 was 58.83.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Harbin Pharmaceutical Group Co's Inventory Turnover for the quarter that ended in Mar. 2024 was 1.55.
Harbin Pharmaceutical Group Co Inventory-to-Revenue Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Harbin Pharmaceutical Group Co Inventory-to-Revenue Chart
Competitive Comparison of Harbin Pharmaceutical Group Co's Inventory-to-Revenue
For the Drug Manufacturers - Specialty & Generic subindustry, Harbin Pharmaceutical Group Co's Inventory-to-Revenue, along with its competitors' market caps and Inventory-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Harbin Pharmaceutical Group Co's Inventory-to-Revenue Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Harbin Pharmaceutical Group Co's Inventory-to-Revenue distribution charts can be found below:
* The bar in red indicates where Harbin Pharmaceutical Group Co's Inventory-to-Revenue falls into.
Harbin Pharmaceutical Group Co Inventory-to-Revenue Calculation
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Harbin Pharmaceutical Group Co (SHSE:600664) Inventory-to-Revenue Explanation
An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:
1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.
Likewise, a decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:
1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.
More Related Terms:
1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Harbin Pharmaceutical Group Co's Days Inventory for the
three
months ended in Mar. 2024 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Harbin Pharmaceutical Group Co Inventory-to-Revenue Related Terms
Thank you for viewing the detailed overview of Harbin Pharmaceutical Group Co's Inventory-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Harbin Pharmaceutical Group Co (SHSE:600664) Business Description
Harbin Pharmaceutical Group Co Ltd is engaged in manufacturing, trading and research and development of pharmaceuticals. The company is organized into seven business segments - Antibiotics, Small-Molecular drug preparations, OTC and healthcare products, Modern Chinese medicines, Biopharmaceuticals, Animal vaccines, and medicine circulations. The company sells its products across China and fifty other countries. Some of its brands are - Hayao, Sanjing, Gaizhonggai, Hutong, and Shiyitang.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SHSE:600664 has been successfully added to your 